These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M. CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501 [Abstract] [Full Text] [Related]
12. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study. Diener HC, Evers S. Clin Drug Investig; 2007; 27(1):59-66. PubMed ID: 17177580 [Abstract] [Full Text] [Related]
13. The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects. Yates RA, Tateno M, Nairn K, Ikegami A, Dane A, Kemp J. Eur J Clin Pharmacol; 2002 Jul; 58(4):247-52. PubMed ID: 12136370 [Abstract] [Full Text] [Related]
14. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ). Winner P, Farkas V, Štillová H, Woodruff B, Liss C, Lillieborg S, Raines S, TEENZ Study Group. Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280 [Abstract] [Full Text] [Related]
15. Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine. Zhou W, Li J, Birmingham B, Xu H, Lillieborg S, Zhou D, Al-Huniti N. J Clin Pharmacol; 2017 Oct; 57(10):1258-1267. PubMed ID: 28581633 [Abstract] [Full Text] [Related]
17. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. Tuchman M, Hee A, Emeribe U, Silberstein S. CNS Drugs; 2006 Oct; 20(12):1019-26. PubMed ID: 17140280 [Abstract] [Full Text] [Related]